Wyszukiwarka
Abstrakt
Infections of Candida spp. etiology are frequently treated with azole drugs. Among azoles, the most widely used in the clinical scenario remains fluconazole (FLC). Promising results in treatment of dangerous, systemic Candida infections demonstrate the advantages of combined therapies carried out with combinations of at least two different antifungal agents. Here, we report five conjugates composed of covalently linked FLC and cell penetrating or antimicrobial peptide: TP10-7-NH2, TP10-NH2, LFcinB(2-11)-NH2, LFcinB[Nle1,11]-NH2, and HLopt2-NH2, with aspects of design, chemical synthesis and their biological activities. Two of these compounds, namely FLCpOH-TP10-NH2 and FLCpOH-TP10-7-NH2, exhibit high activity against reference strains and fluconazole-resistant clinical isolates of C. albicans, including strains overproducing drug transporters. Moreover, both of them demonstrate higher fungicidal effects compared to fluconazole. Analysis performed with fluorescence and scanning electron microscopy as well as flow cytometry indicated the cell membrane as a molecular target of synthesized conjugates. An important advantage of FLCpOH-TP10-NH2 and FLCpOH-TP10-7-NH2 is their low cytotoxicity. The IC90 value for the human cells after 72 h treatment was comparable to the MIC50 value after 24 h treatment for most strains of C. albicans. In reported conjugates, FLC was linked to the peptide by its hydroxyl group. It is worth noting that conjugation of FLC by the nitrogen atom of the triazole ring led to practically inactive compounds. Two compounds produced by us and reported herein appear to be potential candidates for novel antifungal agents.
Cytowania
-
5
CrossRef
-
0
Web of Science
-
6
Scopus
Autorzy (9)
-
Joanna Okońska
-
Jan Lica dr
-
Marek Drab
-
Natalia Ptaszyńska
-
Anna Łęgowska
-
Krzysztof Rolka
Cytuj jako
Pełna treść
- Wersja publikacji
- Accepted albo Published Version
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3390/pharmaceutics14040693
- Licencja
-
otwiera się w nowej karcie
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuły w czasopismach
- Opublikowano w:
-
Pharmaceutics
nr 14,
ISSN: 1999-4923 - Język:
- angielski
- Rok wydania:
- 2022
- Opis bibliograficzny:
- Brankiewicz W., Okońska J., Serbakowska K., Lica J., Drab M., Ptaszyńska N., Łęgowska A., Rolka K., Szweda P.: New Peptide Based Fluconazole Conjugates with Expanded Molecular Targets// Pharmaceutics -Vol. 14,iss. 4 (2022), s.1-18
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3390/pharmaceutics14040693
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 86 razy
Publikacje, które mogą cię zainteresować
Peptide conjugates of lactoferricin analogues and antimicrobials—Design, chemical synthesis, evaluation of antimicrobial activity and mammalian cytotoxicity
- N. Ptaszyńska,
- K. Olkiewicz,
- J. Okońska
- + 9 autorów
Peptide dendrimers as antifungal agents and carriers for potential antifungal agent—N3‐(4‐methoxyfumaroyl)‐(S)‐2,3‐ diaminopropanoic acid—synthesis and antimicrobial activity
- M. Stolarska,
- K. Gucwa,
- Z. Urbańczyk-Lipkowska
- + 1 autorów